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Background: Patients can struggle to make sense of trials in emergency situations. This study examines patient
experience of participating in the United Kingdom, Wound management of Open Lower Limb Fractures (UK WOLLF)
study, a trial of standard wound management versus Negative Pressure Wound Therapy (NPWT).
Methods: The aim of the study was to understand the patient’s lived experience of taking part in a trial of wound
dressings. Interviews drawing on Phenomenology were undertaken with a purposive sample of 20 patients, on average
12 days into their hospital stay from July 2012–July 2013.
Results: The participants were vulnerable due to the emotional and physical impact of injury. They expressed their trial
experience through the theme of being compromised identified in categories of being dependent, being trusting,
being grateful and being without experience. Participants felt dependent on and trusted the team to make the right
decisions for them and not cause them harm. Their hopes for future recovery were also invested within the expertise
of the team. Despite often not being well enough to consent to the study prior to surgery, they wished to be involved
as much as possible. In agreeing to take part they expressed gratitude for their care, wanted to be helpful to others
and considered the trial interventions to be a small component in relation to the enormity of their injury and broader
treatment. In making sense of the trial they felt they could not understand the interventions without experience of
them but if they received NPWT they developed a strong technological preference for this intervention.
Conclusions: Patients prefer to be involved in studies within the limits of their capacity, despite not being able to
provide informed consent. A variety of sources of knowledge may enable participants to feel that they have a better
understanding of the interventions. Professional staff need to be aware of the situated nature of decision making
where participants invest their hopes for recovery in the team.
Trial registration: Current Controlled Trials, ID: ISRCTN33756652. Registered on 24 February 2012.
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The decision to take part in clinical trials in emergency
circumstances can be problematic, patients are often in
psychological shock, have pain and are receiving medica-
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prior to randomisation with written consent post ran-
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randomisation without a signed consent form difficult
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in the study when they were well enough [1].
Understanding patient experience is an important part
of patient-based evidence [3] and can be used as a basis
for shared decision making between professionals and
patients [4]. Current evidence provides insights into why
patients chose to take part in trials and what the benefits
and challenges might be for them. However, there is a
gap in knowledge about how trials impact on patients
who have experienced traumatic musculoskeletal injury.
To explore this further, two linked studies were under-
taken. The first was to examine patient experience of
traumatic injury, in this case open-fracture of the lower
limb. This experience is reported separately [5, 6]. The
second is reported here and describes the patient experi-
ence of being part of a trial in the context of emergency
interventions. The vehicle for this was the United
Kingdom, Wound management of Open Lower Limb
Fractures (UK WOLLF) a trial of standard wound man-
agement versus Negative Pressure Wound Therapy
(NPWT) [5, 7]. In order to understand trial participation
within their overall experience, a methodological ap-
proach was used that enabled patients to present their
experience of what it was like being in a wound-dressing
trial in emergency circumstances. How they made sense
of the trial was situated in relation to other aspects of
their experience. This patient-informed evidence could
be used in the education of future practitioners involved
in consenting patients to emergency trials in musculo-
skeletal injury.
Previous studies demonstrate a range of reasons for
taking part in trials, benefits and challenges. Altruism is
often identified by patients as important [8–10] along-
side other considerations such as: avoiding surgery and
the risk of infection [11], increased surveillance and con-
tinuity of care or the opportunity to have a new treat-
ment [12], their health and personal implications of
taking part [9]. Understanding trial design can be chal-
lenging and therapeutic misconception can occur where
patients, despite being in a trial, feel their treatment was
tailored to their specific needs [8, 11–13]. ‘Subjects
manifest a therapeutic misconception when they fail to
appreciate the risks and disadvantages of participating
that are inherent in the research design’ and which may
limit their care [14]. In a trial focussed on ankle injury
participants felt a preference for one of the treatments
when consenting but later felt that they had the best
treatment for them. The treatment had become a nor-
mal part of everyday life, despite the participants know-
ing it was randomly allocated. In addition they indicated
that in making a decision to take part they could not
‘know’ the treatments as they had not experienced them.
This suggests that experiential knowledge is important
to how participants make sense of studies [11]. Patientsdo not always remember what a study is about, and
some (including lay people) do not like the idea of being
randomised because they think they will not receive the
best possible treatment [15, 16].
In order to explore the reasons for taking part, benefits
and challenges within the context of the experience of
traumatic injury the research question for the study was:
what are patients’ experiences of taking part in a trial of
standard wound management versus NPWT whilst they
are in acute care.
Methods
This study was embedded in a clinical trial comparing
standard wound management with NPWT. Patients
were recruited who had an open fracture of the lower
limb (where the bone protrudes through the skin). Due
to exposure of the wound to air and debris, infection is
a risk and early surgical intervention is required to clean
the wound and remove damaged tissue. The primary
outcome was the Disability Rating Index at 12 months.
Consent for the study was taken if the patient had cap-
acity. If it was judged that the patient did not have cap-
acity, either a family or friend acted as personal
consultee or a surgeon not directly related to the trial
acted as a nominated consultee. After their surgery,
when capacity was regained, participants were informed
of the study. They were provided with a written informa-
tion sheet which included a diagram of the NPWT sup-
ported by verbal discussion before deciding whether
they would like to consent to continue in the study.
The methodology drew on phenomenology using in-
terviews to illicit participants’ lived experience of taking
part in the trial [5]. This approach allowed participants
to present what it is like to be in the world from their
perspective in light of their past history and social con-
text [17]. The aim was to understand what it was like for
them to participate in the trial of wound dressings, in
the context of an open fracture of the lower limb. To en-
able participants to express their experience in their own
words the interviews were lightly structured around the
question: What is it like to take part in the trial?
followed up with prompts, such as How did that feel?
What did you think?, and tell me a bit more about that.
Under the terms of approval granted by the Local
Research Ethics Committee (reference 10/57/20, 6
February 2012), a purposive sample of 20 patients who
had consented and one who had declined to take part in
UK WOLLF were interviewed from July 2012–July 2013.
The participant interviewed who chose not to go into
the study had an aversion to undertaking paperwork,
due to his experience of school life. On average they
were 12 days post first surgical intervention and in-
cluded a range of ages, gender and experience. All the
participants had a severe open fracture of the lower limb
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tained at work, at home or from road traffic collisions.
The interviews took place within the ward area and were
54 min long on average. The interviews were
audio-digitally recorded and transcribed verbatim. Ana-
lysis took place drawing together codes derived from
meanings inherent in the interviews, drawing them to-
gether into categories and themes or ‘structures of ex-
perience’ [18]. NVivo 10 a software package was used to
help manage the data. Rigour was demonstrated through
trustworthiness which included immersion in the data,
providing an audit trail with participants’ quotes and re-
flections in field notes and with peers [19].
Results
The findings from this study identify the theme of
being compromised expressed through the categories of
being dependent, being trusting, being grateful and
being without experience which reflects the partici-
pant’s experience of being asked to be in the UK
WOLLF trial [5, 6]. Being compromised in this study
was defined as: a way of living that enabled participants
to engage in the trial within their current experience of
vulnerability as a result of injury. It was expressed
through trust in the research as well as the clinical
team to do their best and to facilitate their longer-term
recovery. They made sense of the treatments within the
context of injury and its effect on their life whilst
knowing that they lacked understanding and personal
experience of the treatments.
Category: being dependent on others
The participants recognised their vulnerability and were
aware of their compromised state at the time of being
told about the trial. They noted that they were ‘not quite
with it’ (participant 11) and ‘I would not have made
much sense’ (participant 8); consequently they were
dependent on others to make the decision for them.
Those that could remember being told about the trial
felt that the intervention was of minimal concern to
them as both were used in practice:
I was informed about it on the first day and I can half
remember being informed about it because I was on
gas and air and morphine, tramadol, I was on all sorts
of stuff the first day, but yes I can remember being
asked about it. I can remember agreeing to it then but
not (being) quite with it. Then they mentioned it
afterwards and yes I can’t really see it having that
much effect on me. It sounds like they’re both widely
used and they both do their job and as long as it does
its job I have absolutely no qualms about it. Yes,
absolutely no worries about it at all and if it helps
discover the best way to sort out open fractures thenI’m more than happy to be a guinea pig as it were,
that doesn’t bother me. Participant 11
In general, the participants preferred to be involved in
the study to the degree in which they were able. Some
felt early information helped them to make sense of the
study when consent was obtained for continued enrol-
ment in the study at a later stage. The type of wound
dressing was considered less important than other thera-
peutic activity such as being ‘fixed’, but they valued
knowing about their treatment decisions. They were
aware that often choice is limited and balanced this with
the impact on their life:
I would rather that they woke me up and asked me
given the choice...as far as I’m concerned there was no
invasion of my privacy, it was just to see what
dressing worked best it’s neither here nor there as far
as I’m concerned. If no-one had ever told me I would
have been no worse off, it wouldn’t have affected my
life in any way. Participant 15
The low demands on their time and effort made by
the study process in relation to activity whilst in hospital
and follow-up visits was considered a benefit alongside
the ease at which they could withdraw from the study:
It genuinely didn’t bother me about that and I felt free
at any point to say no. It was made very clear to me
that it was voluntary and I could withdraw at any time
so I didn’t have any qualms about it at all…had it been
more intrusive or more that they needed to check me
every week or something like that, than logistically
I wouldn’t have been able to do that. Participant 16
Being dependent on others, due to the severity of their
injuries, was accepted as a normal part of care and
something they had little control over. The nature of
the intervention in this study was acceptable as both
were used in routine practice and it was considered a
low-risk intervention compared to the invasive surgical
interventions that they were receiving. Their views of
the study were, therefore, situated within their broader
experience of injury. However, they understood that
they had limited capacity prior to randomisation but
participants generally wished to be involved as much as
they were able.
Category: being trusting
There was an enormous degree of trust invested in the
clinical team due to the severity of the nature of the in-
jury, and this was extrapolated to the research team; the
research team being integrated into the clinical team
looking after the patients’ overall care. Both teams were
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would know what was best for each individual:
I’m stood here to tell the tale and I’m just glad of that
and taking part in any trials or vacuum pumps
(NPWT) as such, the decisions were made for me as
I wasn’t in a fit state of mind to do that at the time.
To be honest, even if I was I would have agreed to it
anyway. If they had said to me they had got this and
that I would have said to them straight, what do you
think? I would have passed the buck back, which was
the best one… Participant 3
Trust in the team was based on hope that with the
team’s support they had a future. The need to trust and
believe in the team overshadowed their feelings about
the type of dressing they received:
Bring me out the other side, as long as that happens
I’m happy regardless of how they do it. Participant 5
Trust was interlinked with beliefs about the knowledge
differential between staff and patients in relation to
wound healing. It was felt the clinical and research
teams had greater knowledge and, therefore, should be
making the decisions. Although those with knowledge of
NPWT gained from medical family members would have
preferred to have received it as part of their care:
They know what they’re doing and it’s obviously
better that they’re doing it and I’m not. Participant 14
The severity of their injury left them feeling emotionally
fragile, with strong emotions that they had often never felt
before or only when a family member had died. They felt
their wounds looked visually horrific and they struggled
with pain, lack of mobility and had difficulty imagining
how they could live with such injuries [5, 6]. Trust in the
team was a way of being hopeful about future recovery.
Their own knowledge and skills were limited so they
invested their trust in the expertise of the team.
Category: being grateful
Participants were incredibly grateful for being alive, being
saved and felt very lucky. They wished to give something
back and being part of a trial was one way of fulfilling this
need. Altrusim in the form of the need to help others par-
ticularly those of a certain community, such as motorcy-
clists or the scientific community, were noted:
I thought I felt a bit privileged actually to help in that
respect if that’s the case. You need to try and give
something back. Yes, I was glad to do it, at the end of
the day you have to try and give something back tosomething that’s been good to you, it’s worth doing
isn’t it really and it helps to learn from everyone’s
experience. Participant 10
The notion of reciprocity and wanting to give something
back is evident in clinical trials [12]. The particpants often
had near death experiences and talked extensively of those
who had saved them or undertaken extensive surgical in-
terventions to provide them with a chance of walking
again [5, 6]. They were aware of the intense activity that
have given them a chance of recovery and wanted to sup-
port the development of knowledge that might help
others. Some also felt a sense of belonging to the biking
community and wished to support others who may have a
similar accident in the future.Category: being without prior experience
It was very clear that despite prior discussion of the
treatments participants felt that they had limited under-
standing of the interventions and would only gain this
understanding through experience:
The thing is I have never had this situation before so
it’s not like I can say last time I had standard, this
time I’ve had vacuum and I found the vacuum
(NPWT) is a lot better. I can only tell you what
I know and this is all I know. Participant 5
Once experienced there was a strong preference for
the NPWT as it was considered to have a multitude of
benefits. It was described as clever technology that vis-
ibly drew away ‘dirty’ fluids from the body and provided
a clean area that protected the wound. It was felt to have
an active element leading towards recovery and was psy-
chologically reassuring:
Personally from my viewpoint and psychologically
the vac (NPWT) was very good, it made me feel like
that was a clean space and nothing was getting in
but whether that’s true or not I don’t know, but
psychologically looking at it and seeing everything
you felt like it was very good. Participant 15
Rather than bandages soaking up all the goo that was
coming off to see it being mechanically extracted for
me was, as an engineer, more reassuring than just stood
there. I wouldn’t like to think that my leg could lay in a
puddle of goo when it could be freshly vacuumed, so in
a way I found that reassuring. That was good enough
for me so there were no issues there. Participant 2
The sense of security that the NPWT provided was
within the context of a high level of technological care
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participants:
I had a drain from this wound, I had a catheter, I had
two cannulas and they were taking blood out of this
arm every now and then, I had oxygen, I had an
epidural, I had wires coming out of everywhere, it was
really strange because I woke up and it was …, well I
couldn’t really move but yes so having another tube
wouldn’t have really bothered me at all. Participant 11
Concerns were expressed about the pain of dressing
removal to stickiness and hairs, sensitive skin, managing
the tubes when in bed and when mobilising:
On the flip side, you are very constrained, you are
very scared to move, very frightened of interrupting or
damaging it, it’s bit like with the neckline anything
with tubes and that you don’t want to do too much in
case it causes problems. Participant 15
The standard dressing was accepted as just there and
as long as it did not cause pain and was cleaned appro-
priately participants were happy with them:
Yes, it is a worry but I don’t worry about it because
I see the nurses do it every other day and as long as
I see it being cleaned properly and it is, they’re really
thorough and it doesn’t hurt it’s really helped me to
think actually it’s alright, it’s just part of my leg at the
minute but it will be okay. It’s really good to know.
Participant 1
Knowing gained from experience appeared to be im-
portant to how participants made sense of the study in-
terventions. As they had no experience of injury or
either of the dressings they felt their knowledge of the
interventions was limited so taking part in the study was
an easy decision. Direct experience of the NPWT led to
a preference for this dressing. Experiential knowledge
may, therefore, be a useful additional tool for informing
trial participants about interventions.
Being compromised meant that participants were
dependent on others to act on their behalf until they felt
well enough to consent for themselves. In this acute
period they invested a high degree of trust in the team,
for clinical decisions as well as research, but also in rela-
tion to hope for their future recovery. They wished to be
involved in trial decisions but were aware that they were
compromised by the impact of injury and treatment
diminishing their ability to function normally. Wound
dressings were considered a minor aspect of their care
in relation to the enormity of other therapeutic treat-
ments. Being grateful for their care, altruism based onhelping others and the minimal trial requirements were
facilitators of trial participation. In making sense of the
study they were hampered by their lack of understanding
and experience of the two treatments but showed a pref-
erence for NPWT once experienced.
Discussion
The findings identified that patients found that being
part of a trial was closely aligned to their broader experi-
ence of injury. As the clinical and research teams are in-
tegrated, much of the faith in the clinical team was
extrapolated to the trial and, from the patients’ perspec-
tive, the trial interventions were an integral part of their
clinical care. This was expressed though their trust in
the team as a whole. Another key finding was their pref-
erence for a degree of involvement in the trial despite
not necessarily being able to provide informed consent
before the interventions took place.
Being compromised by traumatic injury placed partic-
ipants in a position where their autonomy or freedom
to act was constrained by their ability to function and
their knowledge about best treatment and care. In
recognising their dependency on others, participants
placed their trust in the knowledge and skills of the
team and their experience so far of being ‘saved’ [5, 6].
Relationships with the clinical team can be crucial with
some trial participants taking a ‘leap of faith’ and basing
participation on feelings about the team rather than in-
formation about the study [9]. The context of emer-
gency care may, therefore, constrain individuals’ ability
to voluntarily choose to take part in a study but Gillies
and Entwistle [20] suggests the emphasis on rational
decision making ignores the social context and rela-
tional aspects of people’s lives. They suggest a move to-
wards supporting autonomy whilst taking these aspects
into account. In this study participants perceived their
degree of choice as limited by the emergency nature of
their condition also identified by patients with other
conditions [9]. Participants were sustained by trust and
hope in the team that they would help them recover.
Hope has been identified as important in recovery from
trauma [21] and may be a way of mitigating uncertainty
regarding further loss of a limb, infection or surgery
and their ability to return to normal. Uncertainty is
often present where, despite a desired outcome, the
way to achieve it is not clear [22]. In major trauma
often the route to recovery is not straightforward for
participants so placing their hope in staff could provide
comfort from the emotional turmoil and uncertainty
that injury generates [5]. Supporting individual auton-
omy to make an informed decision regarding participa-
tion in a trial, therefore, needs to be balanced with an
understanding of the importance of patients’ trust in
the team and hopes for future recovery.
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even when they did not have the capacity to consent to
the study, was important for some patients. Patients in
this trial could be enrolled without their prospective in-
formed consent, through personal or nominated consul-
tees, due to their poor physical and mental state. On
consenting to continue in the study some would have
preferred to be involved prior to randomisation also
noted in other trauma studies [13]. However, overall
they did not experience this decision as morally prob-
lematic as they felt they needed help from professionals
and that wound dressings were minor compared with
the importance of being ‘fixed’. Meaningful involvement
of patients in health care decisions is often a complex
process influenced by many factors [23]. ‘Inclusionary
consent’, a term used to identify gaining permission
within the limits of participants’ capacity whilst formal
agreement is gained from others [24] as used in demen-
tia care may be a helpful way forward. Further consider-
ation of how patients can be involved despite lacking
capacity to provide informed consent is recommended.
In making a decision to take part in the trial the par-
ticipants were constrained by their ability to understand
and make sense of the interventions. They were influ-
enced by altruism, the personal benefits of taking part,
as identified by others [12, 13], and the uncontroversial
nature of the intervention and experience of the team.
The degree of knowledge required for participants to
understand a study and make sense of the study in light
of their experience and current context is difficult to as-
certain. Understanding can be affected by factors such as
literacy, comprehension and inferences gleaned from
staff. A good decision should be more than understand-
ing but include participants experience of what is im-
portant to them and the impact on their life [20]. In this
trial the decision appeared to be easy to make as the in-
terventions were considered minor in relation to the
enormity of other treatments and were both used in
everyday practice so the degree of ‘risk’ was minimal.
They did not mind being part of an experiment, a
‘guinea pig’, whereas in a study of two types of metal-
work there were concerns about the interventions not
being tried and tested [13]. On reflection, and from
those who had experience of the NPWT, there was a
realisation that they could never truly ‘know’ the inter-
ventions without having any experience of them, also
noted in ankle injury [11]. For some there was a sense of
therapeutic misconception; they felt that the surgeon
had chosen the best treatment for them, had limited un-
derstanding of the interventions, risks and randomisa-
tion as found in other trauma studies [13]. In general,
they placed their trust in the team that they would not
consider them for a study that would harm them.
Although sometimes there was surprise they had beenput into a study, there was no sense of randomisation as
unacceptable as identified in other studies [15, 16]. A
strong preference for NPWT once experienced also re-
flects feelings of trust and a sense of security in the use
of technology as noted in critical care [25]. Patients lack
experiential knowledge that they feel would help
decision making and the boundary between clinical and
research interventions is often unclear. It is therefore
recommended that clinical and research staff work
closely on the presentation of research material whilst
being aware of patient perspectives.
Limitations of the study are that the sample was not
chosen to be ethnically diverse. Broader understanding of
cultural experiences may have identified variation in the
trust of the scientific community and the need for a range
of language-appropriate media [21]. Due to the impact of
injury the interviews were based on recall of experience;
different methodological approaches might be able to cap-
ture thoughts, feeling and interactions at the time of being
informed about the study and how perspectives change
over time. In order to consider the transferability of study
findings to other areas a clear account of the sample,
methods and use of participant quotes to support the find-
ings are presented. However, we do not know if wound
dressings would be a minor element of care where the im-
pact of injury is less severe or the dressings were not
already used in current practice.
Conclusion
Within the theme of being compromised, participants in
this study made sense of trials within a context of vulner-
ability. They reported their feelings of dependency on
others, their lack of knowledge and their need to trust and
invest hope in the team for their future recovery. However,
they expressed the desire to be involved in the research
decision-making, even if they could not provide formal
consent prospectively. This study suggests that researchers
involved in trials of emergency interventions should: (1)
be aware that trust and hope in the team are an important
part of patient experience of recovery from injury but a
balance is required between supporting their hope and the
requirement for informed decision making, (2) involve the
potential participant in the trial to the limit of their cap-
acity, even if formal consent is not possible and (3) work
closely with the clinical team when presenting trial infor-
mation and be aware that patients will not necessarily sep-
arate clinical interventions from research interventions.
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